NCT04358107View on ClinicalTrials.gov

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Active, not recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Adrenocortical Carcinoma

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH